Scientists from ICAR's National Research Center on Plant Biotechnology...
Singapore: According to reports, Indian drug giant Cipla has renegotia...
The Modi government has heeded the criticism on adhoc appointments in ...
The guests of honor comprised of Dr Lino Baranao, Hon'ble Minister, M...
Pharma Major Lupin has announced that it has received final approval f...
The Sjögren's syndrome treatment market will experience impressive ...
AstraZeneca and Incyte Corporation has announced a new collaboration t...
Carestream Health was awarded 61 new patents from the US Patent and Tr...
Sanofi-Synthelabo (India) announced the launch of two drugs for type 2...
Odanacatib is an investigational cathepsin K inhibitor to be taken onc...
BioAsia, Asia's largest Biotechnology and Life-sciences forum today an...
The 10th Edition of API (Association of Physicians of India) Textbook ...
Dr Chandra Mittal, professor and associate chair, Department of Bi...
DIAGNOSTICS Growth promise In vitro diagnostics will co...
The global treatment market for Fabry disease will expand in value fro...
With 110.4 per 1,00,000 women in Mumbai being diagnosed with cancer (a...
Clinical development of a new drug comprises about two thirds of ...
Glenmark Generics Inc., USA a subsidiary of Glenmark Generics Limited ...
